Stelios Papadopoulos, Director at BIOGEN IDEC INC. (BIIB), sold 46,675 shares at $172.67 ($8.0M) on 2013-03-11, disclosed to the SEC on 2013-03-12.
Scheduled sale ($8.0M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $172.08 | 31,034 | $5.3M | 66.4% |
| 2 | $172.45 | 5,700 | $983K | 12.2% |
| 3 | $172.67 | 5,975 | $1.0M | 12.8% |
| 4 | $172.72 | 3,966 | $685K | 8.5% |
| Total | $172.26 avg | 46,675 | $8.0M | 100% |
| Filing → |
| EXEL | SELL | 2024-05-22 | $240K | — | Filing → |
| EXEL | SELL | 2022-02-24 | $3.3M | — | Filing → |
| EXEL | SELL | 2021-05-13 | $911K | — | Filing → |